A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Recruiting
Phase 2
Interventional Study
Proteinuric Kidney Disease
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to evaluate the safety, tolerability, and effect on Albuminuria of MZE829 in Adults with APOL1 Kidney Disease.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Key Inclusion Criteria:
* APOL1 high risk genotype of G1/G1, G2/G2, or G1/G2
* Chronic kidney disease with persistent albuminuria
Key Exclusion Criteria:
* Organ or bone marrow transplantation
* History of active cancer within past 2 years, except for treated non-melanoma skin cancer, stage 0 cer…
Contacts